Colorectal cancer: proportion of patients between 50 and 74 years of age at diagnosis with Dukes C, or high risk Dukes B, colorectal cancer who undergo surgical resection who receive adjuvant chemotherapy. | National Quality Measures Clearinghouse

Colorectal cancer: proportion of patients between 50 and 74 years of age at diagnosis with Dukes C, or high risk Dukes B, colorectal cancer who undergo surgical resection who receive adjuvant chemotherapy. | National Quality Measures Clearinghouse

Measure Summaries

NHS Scotland

• Colorectal cancer: proportion of patients between 50 and 74 years of age at diagnosis with Dukes C, or high risk Dukes B, colorectal cancer who undergo surgical resection who receive adjuvant chemotherapy.
• Colorectal cancer: proportion of patients who undergo surgical resection for colorectal cancer who return to theatre to deal with complications related to the index procedure (within 30 days of surgery).
• Colorectal cancer: proportion of patients with colon cancer who undergo CT chest, abdomen and pelvis before definitive treatment.
• Colorectal cancer: proportion of patients with colorectal cancer who are discussed at a multidisciplinary team (MDT) meeting before definitive treatment.
• Colorectal cancer: proportion of patients with colorectal cancer who die within 30 or 90 days of chemotherapy or radiotherapy treatment with curative intent.
• Colorectal cancer: proportion of patients with colorectal cancer who die within 30 or 90 days of emergency or elective surgical resection.
• Colorectal cancer: proportion of patients with colorectal cancer who undergo a surgical procedure involving anastomosis of the colon having anastomotic leak requiring intervention (radiological or surgical).
• Colorectal cancer: proportion of patients with colorectal cancer who undergo curative surgical resection where greater than or equal to 12 lymph nodes are pathologically examined.
• Colorectal cancer: proportion of patients with colorectal cancer who undergo elective surgical resection which involves stoma creation who are seen and have their stoma site marked pre-operatively by a nurse with expertise in stoma care.
• Colorectal cancer: proportion of patients with colorectal cancer who undergo elective surgical resection who have the whole colon visualised by colonoscopy or CT colonography before surgery, unless the non-visualised segment of colon is to be removed.
• Colorectal cancer: proportion of patients with rectal cancer undergoing definitive treatment (chemoradiotherapy or surgical resection) who undergo CT chest, abdomen and pelvis and MRI pelvis before definitive treatment.
• Colorectal cancer: proportion of patients with rectal cancer who undergo a surgical procedure involving anastomosis of the rectum (including anterior resection with total mesorectal excision [TME]) having anastomotic leak requiring intervention (radiological or surgical).
• Colorectal cancer: proportion of patients with rectal cancer who undergo elective primary surgical resection or surgical resection following short course neo-adjuvant radiotherapy in which the circumferential margin is clear of tumour.
• Colorectal cancer: proportion of patients with rectal cancer who undergo elective surgical resection following neo-adjuvant long course radiotherapy or chemoradiotherapy in which the circumferential margin is clear of tumour.
• Colorectal cancer: proportion of patients with rectal cancer with threatened or involved circumferential resection margin (CRM) on pre-operative MRI who receive long course neo-adjuvant chemoradiotherapy.